24/7 Wall Street
19 Oct 2026, 12:45 UTC · 1h ago
Coreweave's Shock Absorber Function Will Be Tested Again
Impact · against what's priced in
The article provides no new catalysts for CRWV or NVDA, as the market has already discounted CoreWeave's insolvency risks and the scale of its growth. While pricing power gains are noted, they are insufficient to overcome the debt-to-equity issues that the market currently treats as a survival risk.
- CRWV+0.00
Already priced in
- The price assumes
The current capital-intensive cash burn
The article confirms a -$5.74 billion free cash flow and 2026 capex of $35-$39 billion, both of which the price already reflects.





